aim
determin
whether
nasopharyng
aspir
npa
cytokin
respons
differ
accord
caus
virus
children
lower
respiratori
tract
infect
lrti
method
npa
children
lrti
caus
respiratori
viru
evalu
base
proven
viral
agent
lrti
patient
divid
four
group
level
determin
elisa
result
patient
influenza
viru
infect
demonstr
significantli
lower
level
three
group
patient
respiratori
syncyti
viru
rsv
infect
show
increas
product
decreas
level
compar
patient
influenza
viru
infect
interestingli
similar
respons
seen
patient
parainfluenza
viru
adenoviru
infect
conclus
result
demonstr
respiratori
virus
induc
differ
local
cytokin
respons
howev
bias
respons
uniqu
rsv
seem
predomin
respiratori
virus
young
children
respiratori
virus
import
caus
lower
respiratori
infect
infant
children
cytokin
thought
import
pathogenesi
inflamm
respiratori
tract
sever
studi
investig
cytokin
profil
nasopharyng
aspir
npa
viral
lower
respiratori
tract
infect
lrti
children
previou
studi
suggest
respiratori
virus
could
stimul
helper
cell
type
cytokin
helper
cell
type
cytokin
despit
scanti
data
avail
appar
cytokin
respons
lrti
quit
differ
accord
caus
organ
previou
studi
demonstr
patient
respiratori
syncyti
viru
rsv
infect
influenza
viru
infect
induc
differ
cytokin
profil
influenza
viru
infect
lead
rapid
proinflammatori
reaction
may
condit
infect
host
subsequ
viru
antigenspecif
defens
cytokin
profil
rsv
infect
children
demonstr
variabl
result
infant
rsv
infect
elicit
predomin
respons
interleukin
il
howev
shown
addit
cytokin
interferon
ifn
significantli
elev
rsv
infect
addit
vitro
model
respiratori
viru
infect
show
differ
respons
cell
infect
virus
result
demonstr
cytokin
respons
cell
infect
differ
respiratori
virus
depend
infecti
agent
host
characterist
cytokin
thought
import
pathogenesi
inflamm
respiratori
tract
lower
respiratori
tract
secret
usual
obtain
cytokin
measur
bronchoalveolar
lavag
bal
invas
techniqu
requir
use
anesthet
young
children
hand
npa
often
use
determin
cytokin
respons
viral
respiratori
infect
children
present
studi
perform
determin
whether
clinic
respons
children
lrti
would
differ
accord
caus
virus
examin
differenti
pattern
concentr
npa
acut
viral
lower
respiratori
infect
accord
caus
organ
total
children
sign
symptom
acut
viral
lrti
admit
korea
univers
anam
hospit
period
month
juli
june
enrol
present
studi
characterist
lrti
symptom
includ
runni
nose
cough
wheez
difficulti
breath
without
fever
total
case
posit
viral
cultur
two
virus
isol
specimen
patient
children
case
singl
viral
cultur
select
studi
group
base
proven
viral
agent
lrti
patient
divid
four
group
patient
influenza
viru
influenza
viru
group
patient
parainfluenza
viru
parainfluenza
viru
group
patient
rsv
rsv
group
patient
adenoviru
adenoviru
group
complet
histori
take
physic
examin
routin
laboratori
test
perform
subject
patient
bacteri
mycoplasm
infect
week
age
exclud
bacteri
mycoplasm
infect
identifi
posit
blood
cultur
bacteria
greater
increas
mycoplasma
antibodi
titer
past
histori
chronic
lung
diseas
asthma
bronchopulmonari
dysplasia
also
exclud
parent
gave
written
inform
consent
children
particip
studi
studi
protocol
approv
hospit
ethic
committe
collect
prepar
specimen
npa
collect
usual
within
first
h
admiss
part
routin
hospit
procedur
small
number
case
admit
nighttim
sunday
npa
collect
sometim
within
h
admiss
polyethylen
suction
cathet
place
nasopharyng
caviti
via
nostril
aspir
conduct
use
suction
pump
npa
collect
patient
use
viru
cultur
cytokin
analysi
specimen
cultur
immedi
place
ml
hh
medium
collect
transport
viru
laboratori
ice
kept
c
cultur
perform
npa
patient
cultur
use
cryopreserv
rmix
cultur
diagnost
hybrid
inc
athen
oh
usa
four
respiratori
virus
influenza
viru
parainfluenza
viru
rsv
adenoviru
identif
rhinoviru
coronaviru
bocaviru
metapneumoviru
perform
part
routin
servic
offer
hospit
virolog
depart
analysi
viral
cultur
posit
case
analys
characterist
includ
age
sex
clinic
diagnosi
cultur
proven
case
clinic
diagnosi
acut
lrti
includ
tracheobronch
bronchiol
pneumonia
measur
total
serum
ige
serum
eosinophil
cation
protein
ecp
blood
eosinophil
count
total
serum
ige
level
measur
use
coatacount
total
ige
irma
diagnost
product
co
lo
angel
ca
usa
serum
ecp
level
measur
use
commerci
avail
fluoroimmunoassay
kit
pharmacia
ecp
unicap
system
feia
pharmacia
diagnost
uppsala
sweden
detect
limit
less
blood
sampl
collect
serum
prepar
serum
ecp
analys
perform
accord
manufactur
instruct
number
peripher
blood
eosinophil
count
blood
sampl
contain
ethylenediaminetetraacet
acid
edta
use
autom
haematolog
analyz
coulter
counter
stk
beckman
coulter
fullerton
ca
usa
cytokin
measur
specimen
weigh
dilut
volum
ml
use
phosphatebuff
salin
pb
final
volum
npapb
solut
record
exact
dilut
npa
calcul
level
npa
measur
use
commerci
elisa
kit
bd
inc
san
diego
ca
usa
accord
manufactur
instruct
detect
limit
pgml
respect
assay
run
duplic
mean
valu
use
statist
analysi
cytokin
level
npa
express
per
millilit
present
mean
sd
assign
cytokin
valu
limit
detect
valu
zero
facilit
statist
analys
valu
serum
total
ige
serum
ecp
blood
eosinophil
count
logarithm
transform
analysi
express
geometr
mean
rang
sd
variabl
compar
four
group
use
oneway
anova
follow
tukey
multipl
comparison
test
frequenc
examin
use
chisquar
test
statist
analys
perform
use
spss
statist
packag
spss
inc
chicago
il
usa
pvalu
consid
statist
signific
clinic
characterist
four
studi
group
summar
tabl
mean
age
rsv
group
significantli
lower
three
group
signific
differ
gender
four
group
howev
male
patient
age
group
geometr
mean
rang
sd
total
ige
level
influenza
viru
group
monthli
distribut
isol
virus
shown
figur
lrti
influenza
viru
parainfluenza
viru
rsv
occur
epidem
lrti
adenoviru
occur
season
year
distribut
princip
viral
agent
identifi
patient
differ
respiratori
syndrom
depict
figur
influenza
viru
mainli
account
pneumonia
tracheobronch
parainfluenza
viru
caus
pneumonia
rsv
frequent
associ
bronchiol
adenoviru
associ
tracheobronch
pneumonia
mean
level
pgml
influenza
viru
group
significantli
lower
parainfluenza
viru
group
pgml
rsv
group
pgml
adenoviru
group
pgml
p
mean
level
pgml
influenza
viru
group
also
significantli
lower
parainfluenza
viru
group
pgml
rsv
group
pgml
adenoviru
group
pgml
p
contrast
mean
level
pgml
rsv
group
significantli
lower
three
group
influenza
viru
group
pgml
parainfluenza
viru
group
pgml
adenoviru
group
pgml
tabl
present
studi
viral
lrti
children
indic
seen
npa
local
inflammatori
cytokin
respons
differ
accord
caus
organ
patient
influenza
viru
infect
shown
lowest
level
highest
level
patient
rsv
infect
show
increas
product
decreas
level
compar
patient
influenza
viru
infect
interestingli
similar
respons
also
seen
patient
parainfluenza
viru
adenoviru
infect
howev
two
group
show
significantli
higher
product
rsv
group
result
suggest
respiratori
virus
induc
differ
local
cytokin
respons
bias
respons
uniqu
rsv
seem
predomin
young
children
previou
studi
shown
variabl
relationship
viral
respiratori
infect
cytokin
respons
howev
small
number
case
involv
rel
short
studi
period
larger
group
patient
longer
studi
period
necessari
order
better
delin
clinic
immunolog
behaviour
respiratori
virus
furthermor
sinc
differ
monthli
distribut
respiratori
viru
infect
case
report
countri
examin
cytokin
respons
involv
larg
seri
lrti
patient
period
month
lower
respiratori
tract
secret
usual
obtain
cytokin
measur
bal
invas
techniqu
make
difficult
obtain
appropri
sampl
analysi
present
studi
use
npa
instead
bal
cytokin
analysi
howev
factor
unlik
affect
result
previou
studi
demonstr
cytokin
npa
compar
lower
respiratori
tract
infant
respiratori
viru
infect
studi
investig
cytokin
profil
npa
patient
rsv
lrti
infant
rsv
infect
significantli
elev
local
product
cytokin
lower
level
addit
sever
infect
patient
associ
less
local
product
convers
studi
shown
level
significantli
elev
nasal
secret
rsv
bronchiol
data
suggest
hostrespons
factor
age
atopi
sever
infect
well
caus
virus
import
determin
local
cytokin
respons
allerg
diseas
caus
stimul
respons
consequ
secret
cytokin
sinc
stimul
ige
synthesi
induc
type
hypersensit
indic
allerg
mechan
may
contribut
pathogenesi
wheez
acut
bronchiol
rsv
infect
compar
rsv
infect
cellmedi
immunolog
respons
influenza
viru
infect
attract
less
attent
predomin
cytokin
relat
immunolog
respons
observ
infant
rsv
infect
predomin
cytokin
respons
observ
infant
influenza
viru
infect
may
explain
differ
clinic
manifest
two
viral
infect
infant
role
pathogenesi
viral
respiratori
infect
rel
well
elucid
hall
et
al
alreadi
specul
direct
antivir
activ
well
cellmedi
immun
may
import
pathogenesi
rsv
ltri
consid
key
cytokin
induc
protect
respons
viral
pathogen
found
rsv
ltri
associ
reduc
local
level
owe
lower
level
patient
rsv
infect
frequent
associ
sever
bronchiol
longer
durat
hospit
although
mean
age
patient
rsv
infect
significantli
lower
three
group
unlik
differ
age
could
affect
differ
level
studi
group
exclud
patient
younger
three
month
age
studi
tcell
mediat
respons
delay
first
week
postnat
age
accompani
impair
capac
produc
studi
found
level
higher
parainfluenza
viru
group
adenoviru
group
influenza
viru
group
quit
report
regard
two
virus
kristjansson
et
al
demonstr
signific
differ
cytokin
level
infant
parainfluenza
viru
infect
rsv
infect
influenza
viru
infect
conclud
infect
parainfluenza
viru
rsv
earli
infanc
preferenti
promot
respons
local
product
adenoviru
also
wellknown
caus
lrti
children
case
infect
selflimit
wherea
sever
case
infect
may
associ
sever
infect
chronic
sequela
hyperluc
lung
bronchiol
obliteran
cytokin
partli
respons
chronic
sequela
infect
sinc
author
propos
adenoviru
produc
significantli
higher
level
induc
immun
respons
wherea
author
shown
differ
compar
rsv
concord
studi
fernandez
et
al
studi
observ
level
higher
adenoviru
group
rsv
group
result
indic
adenoviru
rsv
infect
children
differ
significantli
regard
magnitud
product
found
signific
increas
eosinophil
count
serum
ecp
concentr
rsv
group
find
concord
report
oymar
et
al
serum
ecp
concentr
significantli
higher
patient
rsv
lrti
patient
nonrsv
lrti
potenti
explain
tendenc
eosinophil
inflamm
patient
rsv
infect
cytokin
respons
acut
respiratori
viral
infect
known
vari
accord
durat
infect
howev
durat
symptom
admiss
significantli
differ
four
studi
group
studi
laboratori
diagnos
lrti
made
viru
cultur
instead
pcr
given
patient
includ
studi
proven
posit
viru
cultur
possibl
subject
neg
cultur
might
viral
infect
detect
unabl
detect
viral
etiolog
four
kind
respiratori
virus
npa
children
recruit
studi
may
attribut
limit
viral
cultur
npa
sampl
part
routin
servic
offer
hospit
virolog
depart
nevertheless
abl
obtain
signific
result
patient
proven
viral
etiolog
present
studi
perform
patient
lower
respiratori
infect
period
one
year
obtain
result
rel
larg
number
patient
final
prepar
prospect
studi
determin
long
respiratori
viru
infect
cytokin
imbal
may
persist
summari
found
predomin
cytokin
respons
children
rsv
infect
predomin
cytokin
respons
children
influenza
viru
infect
children
parainfluenza
viru
infect
adenoviru
infect
elicit
cytokin
respons
suggest
seen
npa
local
inflammatori
cytokin
respons
may
differ
children
acut
viral
respiratori
infect
accord
caus
virus
bias
respons
may
uniqu
rsv
infect
seem
predomin
respiratori
viral
infect
young
children
investig
local
cytokin
respons
evolv
common
respiratori
virus
essenti
understand
pathogenesi
distinct
respiratori
viral
infect
develop
proper
treatment
modal
